Cardinal Health Introduces Innovative Compression Solution

Cardinal Health Unveils Next-Generation Compression Technology
Kendall SCD SmartFlow™ Compression System is now available in Europe.
Cardinal Health has announced the launch of its revolutionary Kendall SCD SmartFlow™ Compression System, which promises to deeply enhance the experience of both clinicians and patients. This new product marks the next evolution in the Kendall™ Compression Series, aiming to provide superior prevention against venous thromboembolism (VTE) events.
Why the Kendall SCD SmartFlow™ Matters
The Kendall SCD SmartFlow™ Compression System utilizes clinically validated technology to deliver customised, intermittent pneumatic compression (IPC), significantly increasing blood flow in patients at risk. This advanced equipment not only helps to prevent VTE but also ameliorates issues related to blood circulation, pain, and swelling caused by venous stasis.
“Our team is thrilled to present this innovative system to healthcare providers across the globe,” stated Frederic LeRoy, VP of International Marketing. “The system provides reliable compression therapy that addresses venous stasis symptoms, which can substantially affect patients with fragile blood flow. Its design aims to make clinical workflows more efficient so that healthcare workers can focus on delivering direct patient care.”
How the Technology Works
The Kendall SCD SmartFlow™ Compression System incorporates Vascular Refill Detection (VRD) technology. This intelligent technology features a sequential, gradient, and circumferential sleeve design that enhances blood flow per hour compared to traditional uniform compression therapies. Additionally, VRD technology customises compression cycles to adapt to a patient’s unique vascular refill time, ensuring maximum effectiveness and reducing the risk of stasis.
Focus on Patient Safety and Compliance
The system is equipped with proprietary Patient Sensing™ Technology, which automatically monitors whether the compression therapy is effectively being applied. If a patient is not present or if the sleeves are improperly positioned, an alert will activate to ensure proper treatment. A new feature, the Therapy Tracker, logs the duration of compression therapy, allowing hospitals to improve compliance and bolster patient safety measures.
A Trusted Legacy in Compression Therapy
For over forty years, the Kendall SCD™ compression portfolio has established itself as a reliable choice for healthcare professionals, significantly contributing to the prevention of venous thromboembolism (VTE). Shawn McBride, Regional President for EMEA, expressed, “This newly redesigned system further exemplifies our commitment to ongoing innovation within the Kendall™ range and underscores our extensive expertise in the domain of compression therapy.”
Global Availability of the New System
The innovative Cardinal Health™ Kendall SCD SmartFlow™ Compression System has now launched across Europe, along with markets such as Australia, New Zealand, Brazil, and Korea. Plans are in place to gradually expand availability into other regions, including the Middle East, Africa, Asia, and Latin America, allowing even more healthcare professionals and patients to benefit from this cutting-edge technology.
The company emphasizes its mission to improve healthcare outcomes and promote better patient experiences. Cardinal Health remains dedicated to providing transformative solutions that make clinical environments more effective and patient-centric.
About Cardinal Health
Cardinal Health is a leading distributor of pharmaceuticals and specialty products, a global manufacturer and distributor of medical and laboratory products, and a provider of home-health and direct-to-patient services. Their strong focus on customer-centric solutions drives continuous improvement, innovation, and enhancements to the quality of life for individuals around the world. For more detailed information about Cardinal Health, visit their official website.
Frequently Asked Questions
What is the Kendall SCD SmartFlow™ Compression System?
The Kendall SCD SmartFlow™ Compression System is an advanced device designed to provide intermittent pneumatic compression for preventing venous thromboembolism and improving blood flow.
How does the system enhance patient care?
The system features technology that personalizes compression therapy, optimizes blood circulation, and includes safety alerts to ensure proper application of treatment.
Where is the Kendall SCD SmartFlow™ available?
It is currently available in Europe, Australia, New Zealand, Brazil, and Korea, with plans for further expansion into additional markets.
What technologies are incorporated in the system?
The system includes Vascular Refill Detection technology, Patient Sensing™ Technology, and Therapy Tracker features to enhance the efficacy and safety of compression therapies.
What is Cardinal Health's focus in the healthcare industry?
Cardinal Health focuses on providing healthcare solutions that improve patient outcomes and streamline clinical workflows through innovative products and a customer-centric approach.
About The Author
Contact Dylan Bailey privately here. Or send an email with ATTN: Dylan Bailey as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.